These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 38361178)
1. Tyrosine to threonine ratio was related to heart failure with reduced or mildly reduced ejection fraction. Zhou QF; Yang F; Dai Y; Chen S; Zhang FR; Lu L; Lu QY ESC Heart Fail; 2024 Jun; 11(3):1567-1579. PubMed ID: 38361178 [TBL] [Abstract][Full Text] [Related]
2. High serum fibroblast growth factor 21 levels were related to the prognosis and ventricular remodeling of heart failure patients with mildly reduced and reduced ejection fraction. Fan L; Gu L; Yao Y; Ma G Perfusion; 2024 Mar; 39(2):285-293. PubMed ID: 36321746 [TBL] [Abstract][Full Text] [Related]
3. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction. Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV; Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058 [TBL] [Abstract][Full Text] [Related]
4. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort. Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939 [TBL] [Abstract][Full Text] [Related]
5. Plasma levels of free fatty acid differ in patients with left ventricular preserved, mid-range, and reduced ejection fraction. Zhu N; Jiang W; Wang Y; Wu Y; Chen H; Zhao X BMC Cardiovasc Disord; 2018 May; 18(1):104. PubMed ID: 29843618 [TBL] [Abstract][Full Text] [Related]
6. Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction. Rovai S; Corrà U; Piepoli M; Vignati C; Salvioni E; Bonomi A; Mattavelli I; Arcari L; Scardovi AB; Perrone Filardi P; Lagioia R; Paolillo S; Magrì D; Limongelli G; Metra M; Senni M; Scrutinio D; Raimondo R; Emdin M; Lombardi C; Cattadori G; Parati G; Re F; Cicoira M; Villani GQ; Minà C; Correale M; Frigerio M; Perna E; Mapelli M; Magini A; Clemenza F; Bussotti M; Battaia E; Guazzi M; Bandera F; Badagliacca R; Di Lenarda A; Pacileo G; Maggioni A; Passino C; Sciomer S; Sinagra G; Agostoni P; Eur J Heart Fail; 2019 Dec; 21(12):1586-1595. PubMed ID: 31782225 [TBL] [Abstract][Full Text] [Related]
7. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction. Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction. Huang A; Qi X; Hou W; Qi Y; Zhao N; Liu K Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719 [TBL] [Abstract][Full Text] [Related]
9. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction. Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China. Lyu S; Yu L; Tan H; Liu S; Liu X; Guo X; Zhu J BMC Cardiovasc Disord; 2019 Sep; 19(1):209. PubMed ID: 31477021 [TBL] [Abstract][Full Text] [Related]
15. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction. Moliner P; Lupón J; Barallat J; de Antonio M; Domingo M; Núñez J; Zamora E; Galán A; Santesmases J; Pastor C; Bayes-Genis A Int J Cardiol; 2018 Apr; 257():188-192. PubMed ID: 29415801 [TBL] [Abstract][Full Text] [Related]
16. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study. Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002 [TBL] [Abstract][Full Text] [Related]
17. Geriatric nutritional risk index predicts all-cause deaths in heart failure with preserved ejection fraction. Nishi I; Seo Y; Hamada-Harimura Y; Yamamoto M; Ishizu T; Sugano A; Sato K; Sai S; Obara K; Suzuki S; Koike A; Aonuma K; Ieda M; ESC Heart Fail; 2019 Apr; 6(2):396-405. PubMed ID: 30706996 [TBL] [Abstract][Full Text] [Related]
18. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial. Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087 [TBL] [Abstract][Full Text] [Related]
19. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction. Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N; ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]